Anti-αvβ6 antibodies
US8153126B2 · kind B2 · utility
24Cited by
17References
16Claims
0Family size
Inventors
Key dates
| Filing date | Oct 29, 2008 |
| Grant date | Apr 10, 2012 |
| Priority date | — |
| Expiry date | Oct 29, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/205
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibodies that specifically bind to □v□□. Also included are methods of using these antibodies to treat mammals having or at risk of having □v□6-mediated diseases, or to diagnose □V□6-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.